CGM News: FreeStyle Libre 3 Cleared by FDA for Persons Aged 4 Years and Older with Diabetes
The Abbott FreeStyle Libre 3 is the smallest, thinnest, and most accurate 14-day CGM with a 7.9% MARD, the company says.
Gen Z Youth Want Their Physicians to Ask Them about Social Determinants of Health
A new survey of youth aged 14 to 24 years provides significant support for integrating questions about social needs into routine clinical care.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 1, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Heavy Alcohol Use Strongly Associated with Risk of Early-onset Colorectal Cancer, Study Finds
New research shows excessive alcohol use is strongly associated with an increased risk for colorectal cancer, regardless of genetic risk.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 31, 2022
Time to Benefit Following Intensive BP Reduction in Adults Aged 60 Years and Older
The first study of its kind found that intensive blood pressure control may be most beneficial in older adults with life expectancy greater than 3 years vs less than 1 year.
Treatment Gap: In Patients with ASCVD, Low Use of Statins, High-intensity Statins Persists
One-half of more than 600 000 patients with ASCVD were not prescribed statins at all and only 22.5% were taking a high intensity statin, according to a recent study.
Chronic Migraine: Why we Get it Wrong, Why it Matters
Episodic or chronic? Distinguishing between the 2 types of migraine is essential to ensure optimal treatment. Meet Abigail and Martin. Who has which headache?
CDC: Up to 1 in 5 Adult Survivors Experience Post-COVID Conditions
Compared to persons without evidence of prior infection, survivors are significantly more likely to experience conditions often attributable to post-COVID.
Pfizer Wins Fast Track Designation for Potential NASH Drug Combination
Early phase 2a study results of a combination of the 2 agents previously evaluated as NASH monotherapies led to the FDA award for Pfizer.
Risk for HF Hospitalization in Type 2 Diabetes Lower with First-line SGLT-2 Inhibitor vs Metformin
Initiating T2D treatment with an SGLT2 inhibitor reduced risk for heart failure hospitalization compared to metformin in a new study; cardiovascular outcomes were similar.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 25, 2022
Is There Room for TikTok in Medicine? A Young Clinician Explains
Lead author of a recent study discusses why clinicians may be hesitant to use TikTok and how social media may shape health care going forward.
National Kidney Foundation Urges USPSTF to Prioritize Screening Recommendation for CKD
The USPSTF is rumored to have moved screening for chronic kidney disease to a preventive service it is actively considering and the NFK says, "It's time."
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Kosiborod, a cardiologist, and Skolnik, a family practitioner, agree no single specialty owns that prescription and that "it takes a village to care for a patient."
Monkeypox: What We Know About the Outbreak Now
The CDC reported 1 confirmed case of monkeypox in Massachusetts on May 23rd; Quebec is investigating 17 suspected cases. Find out what we know now about the virus.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
Three Doses of Pfizer’s COVID-19 Vaccine Well Tolerated in Children Under 5 Years of Age
Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.
Metformin, Lifestyle in Prediabetes May Reduce Risk of T2D but Not Major CV Events
Among more than 3000 participants with prediabetes, neither metformin or lifestyle change reduced risk for CV events over 21 years according to Diabetes Prevention Program Outcomes Study investigators.
FDA Grants EUA for At-home Triple Test: COVID-19, Influenza, RSV
The Labcorp home test, available without a prescription, is delivered overnight and includes a return envelope. Results are available in 1-2 days.